Associate Director, Regulatory Affairs Advertising & Promotions Tris Pharma IncAssociate Director, Regulatory Affairs Advertising & PromotionsMonmouth Junction, NJ$180,000–$225,000 / yearTris Pharma, Inc. (www.trispharma.com) is a leading privately-owned US biopharmaceutical company focused on development and commercialization of innovative medicines in ADHD, spectrum disorders, anxiety, pain and addiction addressing unmet patient needs. Bachelors degree in life sciences, pharmacy, medicine or a related discipline and minimum of 7 years' experience as a regulatory reviewer of advertising and promotional materials in the pharmaceutical, biotechnology or related industry REQUIRED.
NewAssociate Director, Marketing, Professional Promotion, HCP Strategy (Head & Neck Oncology) Genmab ASAssociate Director, Marketing, Professional Promotion, HCP Strategy (Head & Neck Oncology)Princeton, NJFor 25 years, its hard-working, innovative and collaborative team has invented next-generation antibody technology platforms and harnessed translational, quantitative and data sciences, resulting in a proprietary pipeline including bispecific T-cell engagers, antibody-drug conjugates, next-generation immune checkpoint modulators and effector function-enhanced antibodies. Strong leadership skills, a collaborative mindset, oncology marketing experience (highly preferred), and a proven record of accomplishment operating in an emerging/developing organization are key to this individual's success.
NewAssociate Director, Marketing, Professional Promotion, Field Activation, (Head & Neck Oncology) Genmab ASAssociate Director, Marketing, Professional Promotion, Field Activation, (Head & Neck Oncology)Princeton, NJFor 25 years, its hard-working, innovative and collaborative team has invented next-generation antibody technology platforms and harnessed translational, quantitative and data sciences, resulting in a proprietary pipeline including bispecific T-cell engagers, antibody-drug conjugates, next-generation immune checkpoint modulators and effector function-enhanced antibodies. Success in this role will require strategic thinking, close collaboration with the field sales teams, strong cross-functional partnerships, and knowledge of the evolving HNSCC marketplace while realizing strategic and tactical synergies that accelerate brand growth.
Training and Promotion Representative I Brightstar LotteryTraining and Promotion Representative INJ Statewide, NJRemote$43,264–$73,882 / yearSupported by industry leaders Brightstar Lottery and Scientific Games, NSNJ offers the opportunity to collaborate with experts, contribute to high‑impact initiatives, and support one of the nation’s most successful and responsible lottery programs. IGT is committed to sustaining a workforce that reflects the diversity of the global customers and communities we serve, and to creating a fair and inclusive culture that enables all our employees to feel valued, respected and engaged.
NewSenior Manager, Marketing, Professional Promotion, (Head & Neck Oncology) Genmab ASSenior Manager, Marketing, Professional Promotion, (Head & Neck Oncology)Princeton, NJFor 25 years, its hard-working, innovative and collaborative team has invented next-generation antibody technology platforms and harnessed translational, quantitative and data sciences, resulting in a proprietary pipeline including bispecific T-cell engagers, antibody-drug conjugates, next-generation immune checkpoint modulators and effector function-enhanced antibodies. This critical role will report to the Director of HCP Marketing Petosemtamab and will be expected to serve as a key operational partner across Professional Promotion, Omnichannel COE, Sales, Training, Medical Affairs, Market Access, Patient Experience, and agency partners to help ensure aligned and seamless execution of customer engagement strategies and promotional initiatives.
Product Manager, Professional Promotion, Gyn-Onc Genmab ASProduct Manager, Professional Promotion, Gyn-OncPrinceton, NJFor 25 years, its hard-working, innovative and collaborative team has invented next-generation antibody technology platforms and harnessed translational, quantitative and data sciences, resulting in a proprietary pipeline including bispecific T-cell engagers, antibody-drug conjugates, next-generation immune checkpoint modulators and effector function-enhanced antibodies. Please note that if you are applying for a position in the Netherlands, Genmab's policy for all permanently budgeted hires in NL is initially to offer a fixed-term employment contract for a year, if the employee performs well and if the business conditions do not change, renewal for an indefinite term may be considered after the fixed-term employment contract.
Associate Director, Global Regulatory Affairs, Advertising & Promotion GenmabAssociate Director, Global Regulatory Affairs, Advertising & PromotionPrinceton, NJFull timeFor 25 years, its hard-working, innovative and collaborative team has invented next-generation antibody technology platforms and harnessed translational, quantitative and data sciences, resulting in a proprietary pipeline including bispecific T-cell engagers, antibody-drug conjugates, next-generation immune checkpoint modulators and effector function-enhanced antibodies. Please note that if you are applying for a position in the Netherlands, Genmab's policy for all permanently budgeted hires in NL is initially to offer a fixed-term employment contract for a year, if the employee performs well and if the business conditions do not change, renewal for an indefinite term may be considered after the fixed-term employment contract.
Director, Regulatory Affairs Advertising & Promotion Acadia Pharmaceuticals IncDirector, Regulatory Affairs Advertising & PromotionPrinceton, NJ$193,400–$241,800 / yearThe position partners closely with cross-functional teams to support the timely approval and distribution of promotional and disease state materials, serves as the primary liaison with the FDA''s Office of Prescription Drug Promotion (OPDP) for advertising and promotional submissions, and contributes to labeling strategies for regulatory submissions across Acadia''s product portfolio. We are developing the next wave of therapeutic advancements with a robust and diverse pipeline that includes mid- to late-stage programs in Alzheimer's disease psychosis and Lewy body dementia psychosis, along with earlier-stage programs that address other underserved patient needs.